For instance, in preclinical studies of fusion-negative rhabdomyosarcoma (FN-RMS), the small molecule inhibitor JI130 significantly inhibited tumor cell growth and promoted apoptosis by suppressing Hes1 expression (188). The gene discussed is HES1; the disease is neoplasm.